SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001855763-22-000002
Filing Date
2022-03-08
Accepted
2022-03-08 17:27:14
Documents
1
Period of Report
2022-03-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7830
  Complete submission text file 0001855763-22-000002.txt   9337
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 305 MARGARET AVENUE KITCHENER A6 N2H 6S4
Business Address
McKechnie William Edward (Reporting) CIK: 0001658613 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39874 | Film No.: 22722866